» Articles » PMID: 29393891

Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells Via Regulation of MicroRNA-34a-5p

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2018 Feb 3
PMID 29393891
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Luteolin (LTL) exerts remarkable tumor suppressive activity on various types of cancers, including non-small cell lung cancer (NSCLC). However, it is not completely understood whether the mechanism of its action against NSCLC is related to microRNAs (miRNAs). In the present study, we investigated the anti-tumor effects of LTL on NSCLC in vitro and in vivo. The results revealed that LTL could inhibit cell proliferation and induce apoptosis in both A549 and H460 cells. In a H460 xenograft tumor model of nude mice, LTL significantly suppressed tumor growth, inhibited cell proliferation, and induced apoptosis. miRNA microarray and quantitative PCR (qPCR) analysis indicated that miR-34a-5p was dramatically upregulated upon LTL treatment in tumor tissues. Furthermore, MDM4 was proved to be a direct target of miR-34a-5p by luciferase reporter gene assay. LTL treatment was associated with increased p53 and p21 protein expressions and decreased MDM4 protein expression in both NSCLC cells and tumor tissues. When miR-34a-5p was inhibited in vitro, the protein expressions of Bcl-2 and MDM4 were recovered, while that of p53, p21, and Bax were attenuated. Moreover, caspase-3 and caspase-9 activation induced by LHL treatment in vitro were also suppressed by miR-34a-5p inhibition. Overall, LTL could inhibit tumorigenesis and induce apoptosis of NSCLC cells by upregulation of miR-34a-5p via targeting MDM4. These findings provide novel insight into the molecular functions of LTL that suggest its potential as a therapeutic agent for human NSCLC.

Citing Articles

FVTF inhibits hepatocellular carcinoma stem properties via targeting DNMT1/miR-34a-5p/FoxM1 axis.

Cao X, Peng J, Qiu Y, Zhu W, Cao J, Zou H Chin Med. 2025; 20(1):32.

PMID: 40050970 PMC: 11884036. DOI: 10.1186/s13020-025-01084-3.


Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases.

Lv J, Song X, Luo Z, Huang D, Xiao L, Zou K Front Pharmacol. 2025; 16:1535555.

PMID: 40012626 PMC: 11861102. DOI: 10.3389/fphar.2025.1535555.


Fungal protein D1 inhibits the proliferation of A549 cells via activating the p53/miR-34a signaling pathway.

Zhang M, Liu F, Gao W, Liu Z J Nat Med. 2025; .

PMID: 39966243 DOI: 10.1007/s11418-024-01869-0.


Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies.

Mahwish , Imran M, Naeem H, Hussain M, Alsagaby S, Al Abdulmonem W Food Sci Nutr. 2025; 13(1):e4682.

PMID: 39830909 PMC: 11742186. DOI: 10.1002/fsn3.4682.


Phytochemical Study and In Vitro Antioxidant Activity of Along with Antitumor Activity of the Isolated -Tiliroside and Luteolin 4'--β-Xyloside.

Bertella A, Smadi A, Benhabrou H, Salvador D, Wrona M, Oliveira H Molecules. 2025; 29(24.

PMID: 39770024 PMC: 11678426. DOI: 10.3390/molecules29245935.


References
1.
Lu H, Hao L, Li S, Lin S, Lv L, Chen Y . Elevated circulating stearic acid leads to a major lipotoxic effect on mouse pancreatic beta cells in hyperlipidaemia via a miR-34a-5p-mediated PERK/p53-dependent pathway. Diabetologia. 2016; 59(6):1247-57. DOI: 10.1007/s00125-016-3900-0. View

2.
Wang J, Zhang Q, Pei S, Yang B . Effect and mechanism of miR-34a on proliferation, apoptosis and invasion of laryngeal carcinoma cells. Asian Pac J Trop Med. 2016; 9(5):494-8. DOI: 10.1016/j.apjtm.2016.03.018. View

3.
Mandke P, Wyatt N, Fraser J, Bates B, Berberich S, Markey M . MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame. PLoS One. 2012; 7(8):e42034. PMC: 3411609. DOI: 10.1371/journal.pone.0042034. View

4.
Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A . Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle. 2007; 6(13):1586-93. DOI: 10.4161/cc.6.13.4436. View

5.
Ji W, Sun B, Su C . Targeting MicroRNAs in Cancer Gene Therapy. Genes (Basel). 2017; 8(1). PMC: 5295016. DOI: 10.3390/genes8010021. View